about
Personalized respiratory medicine: exploring the horizon, addressing the issues. Summary of a BRN-AJRCCM workshop held in Barcelona on June 12, 2014Impact of an Educational Program to Reduce Healthcare Resources in Community-Acquired Pneumonia: The EDUCAP Randomized Controlled TrialFibroblast viability and phenotypic changes within glycated stiffened three-dimensional collagen matrices.Repeated Aspergillus isolation in respiratory samples from non-immunocompromised patients not selected based on clinical diagnoses: colonisation or infection?Microbial etiology and bacterial resistance.Vascular disease in COPD: Systemic and pulmonary expression of PARC (Pulmonary and Activation-Regulated Chemokine)Lung fibrotic tenascin-C upregulation is associated with other extracellular matrix proteins and induced by TGFβ1Clinical features, etiology and outcomes of community-acquired pneumonia in patients with chronic obstructive pulmonary disease.Rainfall is a risk factor for sporadic cases of Legionella pneumophila pneumonia.High Prevalence of Left Ventricle Diastolic Dysfunction in Severe COPD Associated with A Low Exercise Capacity: A Cross-Sectional StudyThe effect of simvastatin on inflammatory cytokines in community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial.Effect of corticosteroids on the clinical course of community-acquired pneumonia: a randomized controlled trialCombined Bronchial Artery Embolization and Endobronchial Resection for Bronchial Carcinoid: A Safety and Feasibility Pilot Study.Systemic and Pulmonary Vascular Remodelling in Chronic Obstructive Pulmonary DiseaseThe microbiome in respiratory medicine: current challenges and future perspectives.Increased AGE-RAGE ratio in idiopathic pulmonary fibrosis.Community-acquired Legionella pneumophila pneumonia: a single-center experience with 214 hospitalized sporadic cases over 15 years.Clinical features, etiology, and outcomes of community-acquired pneumonia in patients with diabetes mellitus.Effect of a 3-step critical pathway to reduce duration of intravenous antibiotic therapy and length of stay in community-acquired pneumonia: a randomized controlled trial.Colchicine Treatment for Tracheobronchial Amyloidosis.Increasing isolation of rapidly growing mycobacteria in a low-incidence setting of environmental mycobacteria, 1994-2015.Impact of antibiotic de-escalation on clinical outcomes in community-acquired pneumococcal pneumonia.Aberrant gene methylation and bronchial dysplasia in high risk lung cancer patients.QuantiFERON®-TB Gold In-Tube for contact screening in BCG-vaccinated adults: A longitudinal cohort study.Successful Healing of Tracheal Radionecrosis: Role of Hyperbaric Oxygen Therapy.Transcutaneous Carbon Dioxide Monitoring in Subjects With Acute Respiratory Failure and Severe Hypercapnia.Impact of pre-hospital antibiotic use on community-acquired pneumonia.Community-acquired pneumonia in very elderly patients: causative organisms, clinical characteristics, and outcomes.Declining mortality among hospitalized patients with community-acquired pneumonia.Needle aspiration techniques in the diagnosis of pneumonia.Fatal lung abscess due to Lactobacillus casei ss rhamnosus.Incidence, timing and risk factors associated with 1-year mortality after hospitalization for community-acquired pneumonia.Infectious etiology of acute exacerbations in severe COPD patients.Prognostic value of serum albumin levels in hospitalized adults with community-acquired pneumonia.Specific IgA against Pseudomonas aeruginosa in severe COPD.Impact of antibiotic therapy on systemic cytokine expression in pneumococcal pneumonia.Erratum to: Fibroblast viability and phenotypic changes within glycated stiffened three-dimensional collagen matrices.[Diagnosis and treatment of nosocomial pneumonia]Usefulness of betalactam therapy for community-acquired pneumonia in the era of drug-resistant Streptococcus pneumoniae: a randomized study of amoxicillin-clavulanate and ceftriaxone.Risk stratification and prognosis of acute cardiac events in hospitalized adults with community-acquired pneumonia.
P50
Q27027259-1BA5FDAA-929A-4D71-90C0-F8EDECC14AE8Q28550197-AA1C35ED-BCE4-44BA-AE65-D44CD05997FAQ30656978-540067E6-C046-4593-A496-B02BE08C296FQ31106825-6E11D948-C14A-4FE3-8EBA-2F081FFB4A2EQ33677501-C5CC891F-8F6E-49A2-9DAA-6FBDA5F1C424Q33703730-E18B204A-41B5-4AE0-A54B-1D34ED678A02Q34010640-68BDE861-0312-4286-A1ED-387CFF71633FQ34105094-3E762F82-347E-4475-81E1-F8574FD86291Q34683959-8CC5B06F-7253-4693-AADB-8C6497E8551BQ34797710-D1203DBE-1B46-4E0F-A9C1-A05D9AF10628Q34903761-CD955908-50EF-41D6-B7CA-7F7A5672E4C3Q35559463-AAD2CB2F-4497-4049-A0B9-4BD9AF3D12FFQ35859105-F6AA7706-7945-4AB5-B7DB-F81A1EEDCA5EQ35980048-F9F22608-5015-4001-B625-1B44B19EBCFFQ36345295-A160F52C-774E-4481-A544-BF0C27B8AF54Q37396756-EDF7197A-68F6-4DC6-BC47-71A023580F1AQ37696804-404DB5C2-9655-4211-BF11-758F5476E8C0Q37726612-5B02A4C7-6E5F-4130-BEB9-55B6D3245578Q38468980-82F3B1A2-3364-41ED-B671-53A33F4CE031Q38726051-98E668A4-03E6-4309-A9E8-42D0FB21DACEQ38742587-6CC4B794-DD2A-4F04-A713-B10B76EC2946Q39231468-F42BB7BD-69CF-4867-B3E5-2E8D0EA61048Q39923511-1D76DC3E-CE12-48CD-B3EF-F271B49AD356Q40074673-F1A3D31B-CE61-4957-AA50-A7BACE06F01DQ40077165-73732751-B8A4-4557-A8A8-25D0CF3473E3Q40086790-546B4E31-0965-48E8-9D31-721D540B239DQ40211408-5D6BF8C7-8114-4924-A3D1-D55CE5DF6FADQ40557443-92EF25F6-3116-4BDB-966E-36EBC62F3514Q40738050-1FE8E7D7-AC1F-45BD-89E7-F8598CB8AC05Q41143354-E79C4213-CB93-4740-9984-F18EFBF908ECQ41884084-F26C981E-C849-4D70-9784-1EA344B1DD83Q42228036-BA596098-4D3E-4E4C-B8A7-F7B9F4C78AA4Q42246951-C05FD554-D0E0-4749-9AA8-AC38B5EB6A7CQ42280239-31219B8D-AA68-4DFE-84B6-880656EA1741Q42370587-97BA9EA4-A75B-4FB0-9B58-08ED3F596517Q43010157-CEA389CB-6E7F-4DF8-8DC3-59D23C93B095Q43191239-F7440305-CBFA-451F-86F4-77BBC211847EQ43470548-52B65928-2127-4E08-974D-F8E4393B15B5Q43580509-31DCA348-8EA0-4B08-8FD4-A3038CDD9E0DQ43615069-D4AA895F-B504-4FF1-9A89-D1151367F787
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Jordi Dorca
@ast
Jordi Dorca
@en
Jordi Dorca
@es
Jordi Dorca
@nl
Jordi Dorca
@sl
type
label
Jordi Dorca
@ast
Jordi Dorca
@en
Jordi Dorca
@es
Jordi Dorca
@nl
Jordi Dorca
@sl
prefLabel
Jordi Dorca
@ast
Jordi Dorca
@en
Jordi Dorca
@es
Jordi Dorca
@nl
Jordi Dorca
@sl
P1053
Q-3617-2016
P106
P1153
7003615567
P21
P31
P3829
P496
0000-0002-8137-878X
P569
2000-01-01T00:00:00Z